论文部分内容阅读
端粒酶是迤今为止已知的最广谱的肿瘤标志物 ,鉴于该酶活性几乎在所有恶性肿瘤中均有表达 ,而且在肿瘤发生、发展过程中有重要作用 ,端粒酶已成为一种新的肿瘤基因治疗靶位点 ,本文综述了近年来在该研究领域中业已取得的成果和有待解决的问题
Telomerase is the most broad-spectrum tumor marker known to date. Given that the enzyme activity is expressed in almost all malignant tumors and plays an important role in tumorigenesis and development, telomerase has become a This is a new tumor gene therapy target site. This article reviews the achievements that have been made in this research field in recent years and the issues that need to be resolved.